ClinConnect ClinConnect Logo
Search / Trial NCT06439212

the Efficacy of Ginger Powder as an Analgesic for Intraoperative and Post- Endodontic Pain Management

Launched by CAIRO UNIVERSITY · May 30, 2024

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of ginger powder capsules as a pain relief option during and after a specific dental treatment called endodontic therapy, which is commonly performed on teeth with severe inflammation. The goal is to see if taking ginger can help reduce pain for patients undergoing this procedure on their lower back teeth, known as mandibular molars.

To participate, you must be between 18 and 45 years old and have one of those lower back teeth showing symptoms of serious inflammation. You should be generally healthy and able to return for follow-up appointments. However, if you are pregnant, allergic to ginger, or have certain other dental or health issues, you would not be eligible. If you join the study, you can expect to receive either ginger powder or a placebo (a pill without active ingredients) to compare their effects on your pain. The trial is currently not recruiting participants, but it aims to provide insights that could improve pain management for dental patients in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients aging between 18-45 years old.
  • 2. Patients with mandibular molar with signs and symptoms of symptomatic irreversible pulpitis.
  • 3. Systemically- healthy patients (ASA I or II).
  • 4. Patients who agree to attend for recall appointments.
  • 5. Patients who can understand pain scale and can sign the informed consent.
  • Exclusion Criteria:
  • 1. Pregnant or lactating female patients.
  • 2. Patients allergic to ginger, articaine or any other medicament material used in the study.
  • 3. History of peptic ulceration.
  • 4. Periapical abscess or fistula.
  • 5. Non-restorable teeth.
  • 6. Moderate or severe marginal periodontitis i.e. pocket probe\>3mm.
  • 7. Patients on Aspirin, Clopidogrel, Dalteparin and Warfarin.
  • 8. Radiographic evidence of external or internal root resorption vertical root fracture, perforation, calcification.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported